Items where Author is "Henzen, C."

2022

Vavanikunnel, J. and Sewing, L. and Triantafyllidou, M. and Steighardt, A. and Baumann, S. and Egger, A. and Grize, L. and Felix, B. and Kraenzlin, M. and Henzen, C. and Meier, C.. (2022) Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif Tissue Int, 111 (6). pp. 587-596.

2016

Bounoure, L. and Gomes, F. and Stanga, Z. and Keller, U. and Meier, R. and Ballmer, P. and Fehr, R. and Mueller, B. and Genton, L. and Bertrand, P. C. and Norman, K. and Henzen, C. and Laviano, A. and Bischoff, S. and Schneider, S. M. and Kondrup, J. and Schuetz, P. and Members of the Working, Group. (2016) Detection and treatment of medical inpatients with or at-risk of malnutrition: Suggested procedures based on validated guidelines. Nutrition, 32 (7-8). pp. 790-798.

2015

Alan, M. and Grolimund, E. and Kutz, A. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P. and the Pro, Hosp study group. (2015) Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study. Journal of Internal Medicine, 278 (2). pp. 174-184.

Grolimund, E. and Kutz, A. and Marlowe, R. J. and Vogeli, A. and Alan, M. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P. and for the Pro, Hosp Study Group. (2015) Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type. Journal of Chronic Obstructive Pulmonary Disease, 12 (3). pp. 295-305.

2014

Schuetz, P. and Friedli, N. and Grolimund, E. and Kutz, A. and Haubitz, S. and Christ-Crain, M. and Thomann, R. and Zimmerli, W. and Hoess, C. and Henzen, C. and Mueller, B. and Pro, Hosp Study Group. (2014) Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study. Diabetologia, 57 (2). pp. 275-284.

Schuetz, P. and Kutz, A. and Grolimund, E. and Haubitz, S. and Demann, D. and Vogeli, A. and Hitz, F. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Marlowe, R. J. and Zimmerli, W. and Mueller, B. and Pro, Hosp Study Group. (2014) Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. International Journal of Cardiology, 175 (3). pp. 464-472.

Zhydkov, A. and Christ-Crain, M. and Thomann, R. and Hoess, C. and Henzen, C. and Zimmerli, W. and Mueller, B. and Schuetz, P.. (2014) Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 53 (5). pp. 559-566.

2012

Berkmann, S. and Fandino, J. and Muller, B. and Kothbauer, K. F. and Henzen, C. and Landolt, H.. (2012) Pituitary surgery: experience from a large network in Central Switzerland. Swiss Medical Weekly, 142. w13680.

2007

Schuetz, P. and Christ-Crain, M. and Wolbers, M. and Schild, U. and Thomann, R. and Falconnier, C. and Widmer, I. and Neidert, S. and Blum, C. A. and Schonenberger, R. and Henzen, C. and Bregenzer, T. and Hoess, C. and Krause, M. and Bucher, H. C. and Zimmerli, W. and Muller, B. and Pro, Hosp study group. (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Services Research, 7. p. 102.